RISE for Domestic Violence

(RISE Trial)

Recruiting at2 trial locations

Overseen by Melissa Dichter, PhD MSW

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Boston University

No Placebo Group

Trial Summary

What is the purpose of this trial?

This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced intimate partner violence (IPV). One intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention includes a single session that includes education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health. Participants will answer surveys about their self-efficacy and other health symptoms (e.g., mental health) right before receiving treatment, 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.

Research Team

Katherine M Iverson, PhD

Principal Investigator

V Boston Healthcare System, BU CASchool Medicine Psychiatry

Melissa Dichter, PhD MSW

Principal Investigator

VA Philadelphia Healthcare System

Eligibility Criteria

This trial is for Veterans Health Administration patients who have experienced intimate partner violence (IPV). Participants should be dealing with issues like PTSD, domestic violence, or depression. The study seeks individuals willing to undergo counseling and complete several health surveys over a period of about 15 months.

Inclusion Criteria

Patients receiving care at an enrolled site/affiliated Community-Based Outpatient Clinic (CBOC)

Report experience of past-year physical, psychological, and/or sexual IPV on an established screening tool used to detect IPV in VHA

Be able to provide informed consent including permission to have intervention sessions recorded

Exclusion Criteria

Severe cognitive impairment

Suicide or homicide intent with a specific plan

I have not treated or have unstable mania or psychosis.

Treatment Details

Interventions

• Advocacy-based ECAU (Behavioral Intervention)
• RISE (Behavioral Intervention)

Trial Overview The study compares two brief counseling interventions: RISE, which involves up to 8 sessions covering various topics related to IPV; and Advocacy-based ECAU, a single session focused on education about IPV, safety planning, and resource information. It aims to determine which method better improves self-efficacy and health outcomes.

Participant Groups

Group I: RISE (Recovering from Intimate Partner Violence through Strengths and Empowerment) Experimental Treatment 1 Intervention

Participants randomized to the RISE arm will have 1 or more RISE sessions.

Group II: Advocacy-based ECAU (Enhanced Care as Usual) Active Control 1 Intervention

Participants randomized to this arm will have a single Advocacy-based ECAU session

Who Is Running the Clinical Trial?

Boston University

Lead Sponsor

Trials

494

Recruited

9,998,000+

Sophie Kornowski

Boston University

Chief Executive Officer since 2022

MBA from the University of Chicago, Doctorate in Pharmacy from Paris Descartes University

Dr. Patrizia Cavazzoni

Boston University

Chief Medical Officer

MD from McGill University

VA Minnesota Healthcare System

Collaborator

Patient-Centered Outcomes Research Institute

Collaborator

Trials

592

Recruited

27,110,000+

Nakela L. Cook

Patient-Centered Outcomes Research Institute

Chief Executive Officer since 2020

MD, MPH

Harv Feldman

Patient-Centered Outcomes Research Institute

Chief Medical Officer

MD, MSCE

VA Boston Healthcare System

Collaborator

Trials

73

Recruited

971,000+

VA Philadelphia Healthcare System

Collaborator